-transparent.png){kind=logo}
We have evaluated the absorption and the penetration of metronidazole into the bronchial secretions and saliva in acute infective exacerbations of chronic bronchitis. Seventeen patients were given 400 mg orally three times daily for seven days and "steady state" levels were measured in serum, saliva, and sputum on the last day of treatment. Mean levels in the three biological fluids were not significantly different. Higher metronidazole levels in sputum tended to occur in patients with higher serum levels. In all but one patient, levels in serum and saliva were well within the therapeutic range. We conclude that this oral regimen results in therapeutic tissue levels in acute exacerbations of chronic bronchitis.
D Siegler, and
C M Kaye, and
S Reilly, and
A T Willis, and
M G Sankey
December 1966,
Physiotherapy,
D Siegler, and
C M Kaye, and
S Reilly, and
A T Willis, and
M G Sankey
October 1988,
Journal of postgraduate medicine,
D Siegler, and
C M Kaye, and
S Reilly, and
A T Willis, and
M G Sankey
October 1997,
Hospital practice (1995),
D Siegler, and
C M Kaye, and
S Reilly, and
A T Willis, and
M G Sankey
December 1994,
Postgraduate medicine,
D Siegler, and
C M Kaye, and
S Reilly, and
A T Willis, and
M G Sankey
April 1996,
Postgraduate medicine,
D Siegler, and
C M Kaye, and
S Reilly, and
A T Willis, and
M G Sankey
April 2000,
Current opinion in infectious diseases,
D Siegler, and
C M Kaye, and
S Reilly, and
A T Willis, and
M G Sankey
May 1970,
Thorax,
D Siegler, and
C M Kaye, and
S Reilly, and
A T Willis, and
M G Sankey
January 1974,
Thorax,
D Siegler, and
C M Kaye, and
S Reilly, and
A T Willis, and
M G Sankey
September 1997,
International journal of antimicrobial agents,
D Siegler, and
C M Kaye, and
S Reilly, and
A T Willis, and
M G Sankey
June 2012,
The European respiratory journal,
